The biosimilar approvals do not include Simponi and Simponi Aria’s indications outside of rheumatoid arthritis and ulcerative colitis.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-approves-first-golimumab-biosimilars-treat-rheumatoid-2026a1000fyd?src=rss
Author :
Publish date : 2026-05-18 10:48:00
Copyright for syndicated content belongs to the linked Source.